Point State Capital LP Merck & Co., Inc. Call Options Transaction History

Point State Capital LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $246 Million - $276 Million	-3,345,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $64.7 Million - $81 Million	895,000 Added 36.53%	3,345,000 $256 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $172 Million - $189 Million	2,400,000 Added 4800.0%	2,450,000 $184 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $3.66 Million - $4.15 Million	50,000 New	50,000 $4.15 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $14 Million - $16.3 Million	-200,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $13.9 Million - $15.9 Million	200,000 New	200,000 $16.6 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.